(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 17.75% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.63%.
Icu Medical's revenue in 2023 is $2,042,508,000.On average, 2 Wall Street analysts forecast ICUI's revenue for 2023 to be $57,676,918,219, with the lowest ICUI revenue forecast at $57,028,216,264, and the highest ICUI revenue forecast at $58,325,620,175.
In 2024, ICUI is forecast to generate $60,488,759,412 in revenue, with the lowest revenue forecast at $60,488,759,412 and the highest revenue forecast at $60,488,759,412.